Press release
European cancer monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026
European cancer monoclonal antibodies market is estimated to grow at a CAGR of 8.0% during the forecast period. Increasing launches of monoclonal antibodies biosimilars is offering an opportunity for market growth. For instance, in April 2020, Pfizer Inc. declared the European Commission approval of RUXIENCE (rituximab). It is a monoclonal antibody and biosimilar to MabThera (rituximab), which aims to treat granulomatosis with polyangiitis, chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, rheumatoid arthritis, microscopic polyangiitis, and pemphigus vulgaris. The biosimilars' approval including RUXIENCE is an essential development to treat certain cancers and autoimmune conditions. It offers effectiveness to improve access to treatment access while minimizing healthcare costs.A full Report of European cancer monoclonal Antibodies Market Available at https://www.omrglobal.com/industry-reports/european-cancer-monoclonal-antibodies-market
Additionally, in February 2018, Celltrion Healthcare declared the European Commission approval of Herzuma (trastuzumab biosimilar, CT-P6). This is intended for all indications offered by reference trastuzumab in the EU. It is the third Celltrion Healthcare product that was approved in the EU and established on the company’s increasing biosimilar portfolio. This has led the company to market Herzuma in all 28 EU member states and the European Economic Area to treat patients suffering from metastatic breast cancer, early breast cancer, or metastatic gastric cancer. These launches of biosimilars represent the European Commission's focus towards increasing access to cancer treatment in the region, which in turn, will accelerate the market growth.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-cancer-monoclonal-antibodies-market
Scope of the European Cancer Monoclonal Antibodies Market
Market Coverage
• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Countries Covered- UK, Germany, France, Spain, Italy, and Rest of Europe
• Competitive Landscape- AstraZeneca plc, Pfizer Inc., F- Hoffman La-Roche AG, Novartis AG, and Mylan N.V.
Recent Strategic Initiatives in the European Cancer Monoclonal Antibodies Market
• In June 2020, Sanofi S.A. declared the European Commission approval of Sarclisa (isatuximab) along with dexamethasone (pom-dex) and pomalidomide to treat adults suffering from relapsed and refractory multiple myeloma. It is a monoclonal antibody that attaches to a particular epitope on the CD38 receptor of MM cells.
• In January 2020, Roche declared that the European Commission has permitted conditional marketing authorization for Polivy (polatuzumab vedotin), along with bendamustine plus MabThera (rituximab) (BR), to treat adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are not candidates for a haematopoietic stem cell transplant.
Key questions addressed by the report
• What is the market growth rate?
• Which country/segment dominates the market in the base year?
• Which country/segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
European Cancer Monoclonal Antibodies Market-Segmentation
By Type
• Naked
• Conjugated
• Others (Bispecific)
By Application
• Breast Cancer
• Liver Cancer
• Blood Cancer
• Brain Cancer
• Colorectal Cancer
• Others
European Cancer Monoclonal Antibodies Market– Segment by Country
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Company Profiles
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche AG
• Genmab A/S
• GlaxoSmithKline plc
• Innate Pharma S.A.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/european-cancer-monoclonal-antibodies-market
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release European cancer monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026 here
News-ID: 2189752 • Views: …
More Releases from Orion Market Research
Loader Buckets Market to see Huge Growth by 2028
Market experts do detailed market study about entire market from several angles to depict the most updated and key market data to form this detailed Loader Buckets Market research report and help startups to reinforce their presence. This report further aims at covering vital data and figures on major areas such Asia Pacific, North America, Middle East, Europe, Latin America and Africa. Business participants can also obtain larger gains as…
Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market…
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry.
Key Players
Belgard
Acme Brick Company
The Belden Brick Company
Wienerberger
Pine Hall Brick
Redland Brick
By Type
General Brick Pavers
Wall…
Global Famciclovir Market Top Leading Players with Strategies and Forecast 2028
The global famciclovir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Famciclovir is used to herpes zoster generally called shingle (a rash that can occur in people who have had chickenpox in the past). It's also used to treat persons with a healthy immune system who have recurrent herpes virus cold sores or fever blisters. The herpes simplex virus causes cold sores. When this virus enters the…
More Releases for Europe
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
Global Strategy Consulting Market Research Report 2018-2025 | Global Key Player …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Strategy Consulting Market Size, Status and Forecast 2018-2025” which provides an outlook for current market value as well as the expected growth of Strategy Consulting during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export…
Strategy Consulting Market Deep Insights with Core Business Strategies 2018 - Ro …
Strategy Consulting Market report provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
Global strategy consulting market size status and forecast 2025 has a vast collection of market research reports concerning the software industry, its sub-sectors, and…
Wearable Heart Monitoring Devices Market 2018 To 2023 – Top Leaders Beurer Gmb …
The Worldwide Wearable Heart Monitoring Devices Market is growing at a healthy rate. The major players in this market are Medtronic (U.S.), Kinetec Products UK Ltd. (South America), Beurer GmbH (Europe), Medisana AG (Europe), Briggs Healthcare (U.S.), Polar Electro (Europe), SUUNTO (Europe), Koninklijke Philips N.V. (Europe), Garmin Ltd. (Europe) and others. The Wolrdwide Wearable Heart Monitoring devices is segmented on the basis of products, type, application, and end users. On…
Surgical Equipment Market 2018 Leading Manufacturer in Europe, the Middle East & …
The Europe, the Middle East & Africa Surgical Equipment Market is expected to grow at an approximate CAGR of 6.7% during the forecast period.
A surgical equipment is a designed tool or device to carry out various surgical procedures so as to modifying biological tissues and to provide access for viewing them. The surgical equipment can be designed specifically for a particular surgery or it can be used as general purpose…
